ProJect Pharmaceutics GmbH logo — Formulations for pioneering drugs.

ProJect Pharmaceutics GmbH

Formulations for pioneering drugs.

Founded 2010 Germany Germany 13 employees Biotechnology, Pharmaceutical

General Information

Company Name ProJect Pharmaceutics GmbH
Founded Year 2010
Location Germany Germany +1
Employees 13
Industries Biotechnology, Pharmaceutical
Social

Get notified when ProJect Pharmaceutics GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ProJect Pharmaceutics GmbH

At ProJect Pharmaceutics, we transform chemical and biological ingredients into pioneering therapies. As specialists in formulation science and pharmaceutical process development, we bring deep expertise in recombinant proteins, ADCs and cytotoxics, and live virus vaccines. We do not just formulate drugs - we enhance their intrinsic value. Every day, we design optimized pharmaceutical formulations and delivery systems that maximize safety and application convenience. We develop cost-effective fill and finish processes, tailored for the formulation and delivery system of choice, and seamlessly scale from our pilot lab to large-scale commercial manufacturing. What sets us apart is our ability to develop Antibody Drug Conjugates (ADCs), combining advanced protein formulation and process know-how with cytotoxic drug expertise - a rare combination in the biopharmaceutical industry. Our new safety facilities (GMO S2 and BSL-2) in dedicated labs, together with our profound understanding of live virus formulation and processing, enables us to deliver precise solutions for these highly complex products. Our expertise: • Drug formulation development for all kinds of recombinant proteins and protein conjugates • High protein concentration formulations • Formulation & lyophilization process development for highly potent drugs, including ADCs • Downstream process development • Material compatibility assessment • Clinical administration and in-use studies • Robust lyophilization processes - efficient, optimized, and scalable • Formulation and lyophilization process development for live virus vaccines • Preclinical study material manufacturing • Technology-transfer & scale-up to GMP-manufacturing Our promise • Optimized formulations for biopharmaceuticals • Tailored manufacturing processes ready for transfer to GMP manufacturing • Development reports designed for seamless regulatory submission

No funding data available for ProJect Pharmaceutics GmbH yet.

Get notified when ProJect Pharmaceutics GmbH raises funding

ProJect Pharmaceutics GmbH Alternatives & Competitors

ProJect Pharmaceutics GmbH vs

Empowering Pharmaceutical Innovation, Improving Quality of Life, Safeguarding Human Health

Series B
80 employees
Biopharma, Biotechnology
ProJect Pharmaceutics GmbH vs

Fostering Value through Innovation

155 employees
Biotechnology, Manufacturing
ProJect Pharmaceutics GmbH vs

Unique Affinity Solutions for Biopharmaceutical Manufacturing and Biotherapeutics

43 employees
Biotechnology, Pharmaceutical

FAQ About ProJect Pharmaceutics GmbH

Formulations for pioneering drugs.
ProJect Pharmaceutics GmbH was founded in 2010.
ProJect Pharmaceutics GmbH is headquartered in Germany.
ProJect Pharmaceutics GmbH operates in the following industries: Biotechnology, Pharmaceutical.
ProJect Pharmaceutics GmbH has approximately 13 employees.
Top alternatives and competitors to ProJect Pharmaceutics GmbH include BioDlink(TOT BIOPHARM), Cerbios-Pharma SA, Navigo Proteins GmbH, Kemp Proteins, Laurus Bio . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ProJect Pharmaceutics GmbH and BioDlink(TOT BIOPHARM) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ProJect Pharmaceutics GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy